Notice - Prescription Drug List (PDL): Mometasone furoate

Name: Notice - Prescription Drug List (PDL): Mometasone furoate
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to allow the nonprescription use of Mometasone furoate for the conditions listed below. Only the Human part of the PDL was revised.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-29

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice - Prescription Drug List (PDL): Mometasone furoate (English, HTML) HTML
Notice - Prescription Drug List (PDL): Mometasone furoate (French, HTML) HTML

Related open data

Health Canada